Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Measuring Reading Rehabilitation Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00125632
Recruitment Status : Completed
First Posted : August 1, 2005
Last Update Posted : February 5, 2009
Information provided by:
VA Office of Research and Development

Brief Summary:
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with age-related macular degeneration.

Condition or disease Intervention/treatment Phase
Age Related Maculopathy Retinal Degeneration Procedure: Eccentric Viewing Training for Reading Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Double
Official Title: Measuring Reading Rehabilitation Outcomes
Study Start Date : August 2005
Actual Study Completion Date : May 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Primary Outcome Measures :
  1. Participants will be given the following assessment tests at 4 different times during the assessment (at baseline, after 6 weeks, after 12 weeks, and after 18 weeks): eye tracking measures, daily performance measures and reading measures.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with a diagnosis of AMD
  • An established preferred retinal locus
  • Visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the better eye)

Exclusion Criteria:

  • Those with other major ophthalmologic and neurologic disease; choroidal neovascularization ("wet" AMD); moderate to severe media opacities; and cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00125632

Layout table for location information
United States, Illinois
Jesse Brown VA Medical Center
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
US Department of Veterans Affairs
Layout table for investigator information
Principal Investigator: Janet P Szlyk, Ph.D. Research & Development Service 151, Jesse Brown VA Medical Center

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information Identifier: NCT00125632    
Other Study ID Numbers: O3877R
First Posted: August 1, 2005    Key Record Dates
Last Update Posted: February 5, 2009
Last Verified: December 2006
Keywords provided by VA Office of Research and Development:
Treatment Outcomes
Low vision
Additional relevant MeSH terms:
Layout table for MeSH terms
Retinal Degeneration
Eye Diseases, Hereditary
Eye Diseases
Retinal Diseases